Abbott Ends Certiva Agreement In U.S.; NAVA Focuses on NeisVac-C for U.K.
Executive Summary
Abbott has terminated its agreement with North American Vaccine to market its combination diphtheria, tetanus and acellular pertussis vaccine Certiva to private physicians in the U.S.